Correlation Between Allarity Therapeutics and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Allarity Therapeutics and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Biodexa Pharmaceticals.
Diversification Opportunities for Allarity Therapeutics and Biodexa Pharmaceticals
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Allarity and Biodexa is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Biodexa Pharmaceticals
Given the investment horizon of 90 days Allarity Therapeutics is expected to generate 0.53 times more return on investment than Biodexa Pharmaceticals. However, Allarity Therapeutics is 1.88 times less risky than Biodexa Pharmaceticals. It trades about -0.18 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.23 per unit of risk. If you would invest 150.00 in Allarity Therapeutics on August 24, 2024 and sell it today you would lose (24.00) from holding Allarity Therapeutics or give up 16.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allarity Therapeutics vs. Biodexa Pharmaceticals
Performance |
| Timeline |
| Allarity Therapeutics |
| Biodexa Pharmaceticals |
Allarity Therapeutics and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and Biodexa Pharmaceticals
The main advantage of trading using opposite Allarity Therapeutics and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
| Biodexa Pharmaceticals vs. Vita Coco | Biodexa Pharmaceticals vs. Tenaris SA ADR | Biodexa Pharmaceticals vs. Anheuser Busch Inbev | Biodexa Pharmaceticals vs. Patterson UTI Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |